Traditional med goes mainstream

The Council for Scientific and Industrial Research (CSIR) said today it had signed a deal with a UK pharmaceutical company to develop an anti-obesity drug from a plant used by the San people.

“A cooperation agreement has been signed with Phytopharm, a United Kingdom-based pharmaceutical development and functional food company, for further development and commercialisation of Hoodia Gordonii for the management of obesity,” the council said.

The commercialisation process would be led by the CSIR and had the full support of the South African San Council, it added.

CSIR group manager for intellectual property and technology transfer Johan Hattingh said the project would require “scientific innovation and substantial investment in order for it to be successful”.

Clinical studies would be conducted with the help of outside experts to advise the CSIR on the option for developing products using the plant known by the San as “kanna” and “kougoed”.

We live in a world where facts and fiction get blurred
In times of uncertainty you need journalism you can trust. For only R75 per month, you have access to a world of in-depth analyses, investigative journalism, top opinions and a range of features. Journalism strengthens democracy. Invest in the future today.
Subscribe to News24
Lockdown For
DAYS
HRS
MINS
Voting Booth
As a child or as an adult, have you ever been a victim of bullying?
Please select an option Oops! Something went wrong, please try again later.
Results
Yes, at school
55% - 3978 votes
Yes, at work
18% - 1265 votes
No, I've never experienced this
27% - 1978 votes
Vote
USD/ZAR
14.28
(+0.2)
GBP/ZAR
19.87
(+0.1)
EUR/ZAR
17.20
(+0.3)
AUD/ZAR
11.06
(+0.1)
JPY/ZAR
0.13
(+0.2)
Gold
1,786.88
(-0.4)
Silver
26.37
(-0.7)
Platinum
1,206.00
(-0.9)
Brent Crude
65.32
(-1.9)
Palladium
2,855.76
(-0.9)
All Share
66,933
(-0.3)
Top 40
61,142
(-0.4)
Financial 15
12,102
(-0.2)
Industrial 25
86,625
(-0.1)
Resource 10
68,663
(-0.9)
All JSE data delayed by at least 15 minutes Iress logo